event tracking

Peter Laird

25 results.

October 24, 2018 Large-scale cancer study locates “light switches” in the “dark” regions of the genome

Many of cancer’s long-buried secrets are now out in the open thanks to a collaborative effort to catalog the genetic switches that govern…

April 4, 2018 Comprehensive atlas redefines gastrointestinal cancers

Scientists now have a powerful new resource for developing better treatments for common cancers of the esophagus, stomach, colon and rectum, collectively known as gastrointestinal…

April 4, 2018 Van Andel Research Institute scientists help redefine how cancer is categorized

GRAND RAPIDS, Mich. (April 5, 2018) — Van Andel Research Institute (VARI) announced today that the work of its scientists is featured in 27…

April 1, 2018 Scientists discover new method for measuring cellular age
Nature Genetics paper shows cells begin losing important DNA marks in utero

GRAND RAPIDS, Mich., and LOS ANGELES (April 2, 2018) — A team led by scientists at Van Andel Research Institute (VARI) and

June 20, 2017 Research brief: Developing a “roadmap” for the second deadliest cancer worldwide

Epigenetics: Refers to the packaging and marking of DNA, which guides whether genes are on or off and to what extent. Epigenetic errors can lead to…

March 13, 2017 Research brief: Four molecular subtypes revealed in rare bile duct cancer

The short version Scientists now have a new resource for studying a rare bile duct cancer that may serve as a blueprint for placing patients…

January 3, 2017 Comprehensive study of esophageal cancer reveals several molecular subtypes, provides new insight into increasingly prevalent disease

The Cancer Genome Atlas Research Network recommends clinical trials organizers and drug manufacturers focus on newly discovered molecular subtypes GRAND RAPIDS, Mich. (Jan. 4, 2017) –…

November 16, 2016 Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis

GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from the National Cancer…